search
Back to results

Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 Diabetes

Primary Purpose

Type 2 Diabetes Mellitus

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Virtual Diabetes Self-Care and Education Program
Fitbit
Smartphone
Sponsored by
Joslin Diabetes Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes Mellitus focused on measuring Type 2 Diabetes Mellitus, Telehealth, Hispanics, Latinos, Self-Care, Mobile Health, mHealth

Eligibility Criteria

21 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Have physician-diagnosed type 2 diabetes
  • Be self-identified as Hispanic or Latino
  • An A1c value between 8-14% within the last three months.
  • Demonstrate the ability, either alone or with the help of a family member that will be with the patient at least once a week, to use the technology that will be used during the teleconsultations

Exclusion Criteria:

  • Severe diabetes related chronic complications such as chronic renal failure, blindness, amputations, stroke, etc.
  • Concomitant chronic illnesses that would affect their participation in the program, i.e. cancer, debilitating diseases, etc.
  • Any other condition that would affect participant's basic mental health skills
  • Type 1 diabetes or gestational diabetes
  • Patients with abnormal hemoglobin, anemia or any condition that may affect red blood cell turnover. Any of these conditions may be detected through participants' history or through the laboratory report at study screening
  • Signs or symptoms of metabolic decompensation (polyuria, polydypsia, polyphagia, unexplained weight loss, blurry vision, lethargy, etc.)

Sites / Locations

  • Doctors Hospital at Renaissance

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Intervention

Arm Description

Patients in this group will attend regular clinical and education appointments as offered by the clinic for their diabetes care.

Patients in this group will be part of a Virtual Diabetes Self-Care and Education Program. They will receive a phone to communicate with a diabetes educator for 6 months. They will connect with the diabetes educator for weekly video conferences of up to 30 minutes for twelve consecutive weeks, followed by 7 phone calls. Additionally, they will receive a weekly text message about diabetes for 6 months.

Outcomes

Primary Outcome Measures

Hemoglobin A1c
The A1C test is a blood test used to diagnose type 2 diabetes and then to manage diabetes. It is measured as a percent.

Secondary Outcome Measures

Full Information

First Posted
June 4, 2015
Last Updated
August 15, 2022
Sponsor
Joslin Diabetes Center
Collaborators
Verizon Foundation, DHR Health Institute for Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT02488785
Brief Title
Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 Diabetes
Official Title
The Impact of a Comprehensive Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With Type 2 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
June 2015 (Actual)
Primary Completion Date
March 31, 2017 (Actual)
Study Completion Date
November 30, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Joslin Diabetes Center
Collaborators
Verizon Foundation, DHR Health Institute for Research and Development

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this study is to evaluate the impact of a comprehensive diabetes education and management program based on frequent communication with patients using teleconsultation, text messaging, and phone calls on diabetes related outcomes in Latino patients with type 2 diabetes. The investigators hypothesize that the decline in hemoglobin A1c value between the baseline and the six-month visit will be at least 0.5 percent greater in the intervention group than in the control group.
Detailed Description
In this study participants will be followed for a period of 9 months. The control group will receive usual care during this period of time. While, the intervention group will be part of a diabetes education and management program lasting 6 months via a smartphone participants will receive. The 6 month intervention will be followed by a 3 month observation period.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus
Keywords
Type 2 Diabetes Mellitus, Telehealth, Hispanics, Latinos, Self-Care, Mobile Health, mHealth

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
96 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Patients in this group will attend regular clinical and education appointments as offered by the clinic for their diabetes care.
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Patients in this group will be part of a Virtual Diabetes Self-Care and Education Program. They will receive a phone to communicate with a diabetes educator for 6 months. They will connect with the diabetes educator for weekly video conferences of up to 30 minutes for twelve consecutive weeks, followed by 7 phone calls. Additionally, they will receive a weekly text message about diabetes for 6 months.
Intervention Type
Behavioral
Intervention Name(s)
Virtual Diabetes Self-Care and Education Program
Intervention Description
Participants will be able to have frequent contact in order to share physical activity and glucose data with the diabetes educator using the smartphone they will receive. Information downloaded to the Glooko Population Management tool can be shared with the diabetes educator.
Intervention Type
Device
Intervention Name(s)
Fitbit
Other Intervention Name(s)
physical activity tracker
Intervention Description
Participants will be given a Fitbit physical activity tracker which they can use to record their activity and share the information with the diabetes educator using the device's smartphone application.
Intervention Type
Device
Intervention Name(s)
Smartphone
Intervention Description
All virtual visits were performed via provided smartphone. In addition, participants will receive a Glooko MeterSync Blue cable which is able to connect to most glucose meters in order to download glucose data to the Glooko Population Management tool on their smartphones
Primary Outcome Measure Information:
Title
Hemoglobin A1c
Description
The A1C test is a blood test used to diagnose type 2 diabetes and then to manage diabetes. It is measured as a percent.
Time Frame
9 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Have physician-diagnosed type 2 diabetes Be self-identified as Hispanic or Latino An A1c value between 8-14% within the last three months. Demonstrate the ability, either alone or with the help of a family member that will be with the patient at least once a week, to use the technology that will be used during the teleconsultations Exclusion Criteria: Severe diabetes related chronic complications such as chronic renal failure, blindness, amputations, stroke, etc. Concomitant chronic illnesses that would affect their participation in the program, i.e. cancer, debilitating diseases, etc. Any other condition that would affect participant's basic mental health skills Type 1 diabetes or gestational diabetes Patients with abnormal hemoglobin, anemia or any condition that may affect red blood cell turnover. Any of these conditions may be detected through participants' history or through the laboratory report at study screening Signs or symptoms of metabolic decompensation (polyuria, polydypsia, polyphagia, unexplained weight loss, blurry vision, lethargy, etc.)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sylvia E Rosas, MD
Organizational Affiliation
Joslin Diabetes Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marcel Twahirwa, MD
Organizational Affiliation
Doctors Hospital at Reinassance
Official's Role
Principal Investigator
Facility Information:
Facility Name
Doctors Hospital at Renaissance
City
Edinburg
State/Province
Texas
ZIP/Postal Code
78539
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 Diabetes

We'll reach out to this number within 24 hrs